ReviewJournal of neural transmission (Vienna, Austria : 1996)2026
Myopathies in clinical care: a focus on treatable causes.
Review in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myopathies are a group of disorders that affect the skeletal muscles, manifesting as weakness, fatigue, or pain. Generally, they are classified as acquired or inherited. It is important to note that while most acquired myopathies are treatable, in the advent of targeted molecular and gene-based therapy, some inherited forms now have effective therapeutic options. These myopathies can be classified based on their underlying causes, including infections, autoimmune disorders leading to muscle inflammation, metabolic abnormalities within muscle cells, skeletal muscle channel dysfunctions, critical illness myopathy, and inherited conditions such as muscular dystrophies. In this review, we first present a clinical approach to neuromuscular diseases and subsequently place specific emphasis on myopathies, particularly those with established or emerging treatment options.
Indexed as
Identifiers
41762439What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.